Skip to main content

Viridian Therapeutics, Inc.\DE 8-K, filed Nov 2, 2023

Viridian Therapeutics, Inc.\DE (VRDN)

8-K 2023-11-02 For: 2023-10-29
View Original
Added on April 10, 2026

About this 8-K

Viridian Therapeutics, Inc.\DE filed this 8-K on November 2, 2023, reporting on events of October 29, 2023.

Items reported

  • Item 5.02: Director or officer change, or executive pay
  • Item 5.03: Charter or bylaw amendment, or fiscal year change
  • Item 9.01: Financial statements and exhibits